Diabetes, Obesity and Metabolism, 2026
First‐Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial

Chee Y., Acharyya S., Liew H. et al.

Communications Medicine, 2026
Integrative proteogenomic analyses identify plasma proteins that impact the risk of ischemic stroke

Belbasis L., von Ende A., Gajendragadkar P. et al.

Scientific Reports, 2026
Less severe endothelial injury and vascular pathway activation in SARS-CoV-2 Omicron variant compared to Alpha

Tiezzi M., Fortini F., Vandenbempt V. et al.

Acta Pharmaceutica Sinica B, 2026
Reprogramming gut microbiota and targeting CXCL1: The multifaceted mechanism of PLP1 in ameliorating alcohol-induced liver disease

Yang Z., Lv Q., Xu Q. et al.

The Lancet Rheumatology, 2026
Interferon-α as a precision medicine tool in Sjögren's disease: a cohort and experimental medicine study

Forbes D., Jorgacevic I., Tarn J. et al.

The American Journal of Clinical Nutrition, 2026
Height variation independent of known genetic variants and health in later life: a cohort study

Zhang Y., Li Y., Xue X. et al.

JACC: Basic to Translational Science, 2026
Plasma Proteomic Signatures of Left Atrial Dysfunction and Cerebral Small Vessel Disease

Tan E., Sim M., Choi H. et al.

npj Science of Food, 2026
BHOD: a bone health optimized dietary pattern designed for osteoporosis prevention

Zheng Y., Li Y., Gao Y. et al.

BMC Neurology, 2026
A preliminary analysis of the inflammatory protein landscape in the CSF of mid- to late-stage Parkinson’s disease: associations with motor severity and subtypes

Guo Y., Liu W., Bu W. et al.

Frontiers in Medicine, 2026
Reanalysis of the immunological characteristics of scalp psoriasis: a cross-sectional study using Olink proteomics

Zhu L., Chen W., Shen N. et al.

Journal of Advanced Research, 2026
Integrating clinical, proteomics, and polygenic scores to improve cardiovascular risk prediction: a prospective cohort study

Ding Y., Hong G., Wang Z. et al.

Gut Microbes, 2026
Multi-omics analysis of saccharomyces boulardii supplementation reveals coordinated microbiome, metabolic, and immune signaling changes accompanying tumor suppression

Vaaben T., Lützhøft D., Hedin K. et al.

Frontiers in Immunology, 2026
TLR7 signaling aggravates lung inflammation associated with increased anti-Scl-70 autoantibody production in murine bleomycin-induced systemic sclerosis

Evangelista J., Nisperuza Vidal A., Xu D. et al.

Inflammation Research, 2026
Pathway-level proteomics identifies subcellular trafficking dysregulation as a molecular signature in severe traumatic brain injury

Van Nynatten L., Tweddell D., Daley M. et al.

Journal of Inflammation Research, 2026
Paired Tear Fluid – Plasma Inflammatory Profiling Identifies Compartment-Specific Biomarkers for Diabetic Retinopathy and Diabetic Macular Edema

Yu T., Li S., Cheng F. et al.

Psychotherapy and Psychosomatics, 2026
Schizophrenia Genetic Liability Drives Chronic Disease Risk in Unaffected Individuals Through Immune and Metabolic Pathways

Wei W., Cheng B., He D. et al.

Journal of Cardiovascular Translational Research, 2026
The Immediate Impact of Infarct Size on the Systemic Inflammatory Response: IL-6 as Central Mediator Identified through Biomarker and Proteomic Profiling

Los J., Mensink F., Bulut ?. et al.

Hepatology International, 2026
Pathological transcriptional retention of Cyp26b1 in perirenal adipose-derived stem cells contributes to MASLD progression

Zhang Y., Li Z., Sun J. et al.

Frontiers in Nephrology, 2026
Plasma proteomics based on machine learning predict the early risk of kidney outcomes in patients with DKD: a prospective cohort study from UK Biobank

Jiang L., Li T., Zhang H. et al.

International Journal of Biological Macromolecules, 2026
FES suppresses macrophage-mediated inflammation and atherosclerotic plaque formation by modulating the PU.1/Arg1 axis

He M., Liu X., Xu Z. et al.